Emyria Limited (EMD.AX)

0.2900 -0.0050 (-1.69%) At close: 04:10PM AEST

Emyria Limited

D2, 661 Newcastle Street
Leederville, WA 6007
Australia
1300 436 363
https://www.emyria.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.	Exec. Chairman	200k	N/A	1970
Dr. Michael Winlo	MD & Director	376.34k	N/A	N/A
Dr. Alistair Vickery	Exec. Medical Director & Director	371.2k	N/A	N/A
Mr. Joseph Daniel Ohayon ACA, MBA Intl Bus.	Chief Financial Officer	N/A	N/A	N/A
Dr. Karen L. Smith L.L.M, L.L.M., M.B.A., M.D., PH.D.	Exec. Director & Chairman of Strategic Advisory Board	N/A	N/A	1968
Ms. Tracie Ernenwein	Head of Research & Drug Devel.	N/A	N/A	N/A
Mary-Ann Rennie	Head of Corp. Operations	N/A	N/A	N/A
Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA	Company Sec.	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Emyria Limited, a clinical drug development and care delivery company, operates a network of specialist medical clinics. Its product pipeline include EMD-003, a cannabinoid medicine for treating patients with mental health; and EMD-004, a cannabinoid medicine targeting irritable bowel syndrome. The company also provides a data platform that manages, monitors, and improves the safety and efficacy of novel treatments for patients with unmet medical needs. In addition, its medical clinics offer treatments, such as cannabinoid-based medicines. The company has a partnership agreement with Mind Medicine Australia to develop a national care program and data registry for psychedelic-assisted therapies. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.

Corporate governance

Emyria Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.